PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.\', \'Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.\', \'Center for Vaccine Innovation and Access, PATH, Washington, District of Columbia, USA.\', \'Vanderbilt School of Medicine, Nashville, Tennessee, USA.\', \'National Institute of Allergy and Infectious Disease, Rockville, Maryland, USA.\', \'Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.\', \'University of Maryland School of Medicine, Baltimore, Maryland, USA.\', \'Health Ombudsman, Office of Health Standards and Compliance, Pretoria, Republic of South Africa.\', \'Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.\', \'North Carolina State University, Raleigh, North Carolina, USA.\', \'University of Alabama at Birmingham, Birmingham, Alabama, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/infdis/jiab263
?:doi
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34008027
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34008027>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34008027>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all